The Trump administration has awarded a contract worth $1.6 billion to a Maryland biotechnology company to develop a coronavirus vaccine, the ...
News
- Maryland biotech firm wins $1.6 billion to develop coronavirus vaccine
- Feds give Regeneron $450M for production of potential COVID treatment
"This manufacturing and supply agreement with BARDA (Biomedical Advanced Research and Development Authority) and the Department of Defense ...
- $200K loan helped Senate president's business hang on
Biothera, a privately held biotech company where Winkler once worked and where he still retains what he called a small number of shares, was listed ...
- Branford bioscience firm gets NY contract in 'superbug' fight
BRANFORD — The New York State Department of Health has awarded Tangen Biosciences a contract to develop a point-of-care device for detection ...
- Thermo Fisher, Uber rise; Bellus, Dominion fall
The biotechnology company's chronic cough drug failed to meet key treatment goals in a study. Uber Technologies Inc., up $1.84 to $32.52.